Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Other Non Operating Income: 2015-2024

Historic Other Non Operating Income for Gyre Therapeutics (GYRE) over the last 10 years, with Dec 2024 value amounting to -$1.7 million.

  • Gyre Therapeutics' Other Non Operating Income rose 1069.33% to $727,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$945,000, marking a year-over-year decrease of 260.69%. This contributed to the annual value of -$1.7 million for FY2024, which is 9.29% down from last year.
  • Latest data reveals that Gyre Therapeutics reported Other Non Operating Income of -$1.7 million as of FY2024, which was down 9.29% from -$1.5 million recorded in FY2023.
  • In the past 5 years, Gyre Therapeutics' Other Non Operating Income registered a high of $857,000 during FY2022, and its lowest value of -$1.7 million during FY2024.
  • For the 3-year period, Gyre Therapeutics' Other Non Operating Income averaged around -$773,333, with its median value being -$1.5 million (2023).
  • As far as peak fluctuations go, Gyre Therapeutics' Other Non Operating Income surged by 1,198.72% in 2022, and later crashed by 277.13% in 2023.
  • Gyre Therapeutics' Other Non Operating Income (Yearly) stood at -$91,000 in 2020, then climbed by 14.29% to -$78,000 in 2021, then skyrocketed by 1,198.72% to $857,000 in 2022, then tumbled by 277.13% to -$1.5 million in 2023, then declined by 9.29% to -$1.7 million in 2024.